INVANZ is the brand name for the medication Ertapenem, which is an antibiotic used to treat a variety of bacterial infections. It belongs to the class of antibiotics known as carbapenems. INVANZ (ertapenem) is commonly prescribed for the treatment of infections such as:

Complicated intra-abdominal infections
Complicated skin and skin structure infections
Community-acquired pneumonia
Complicated urinary tract infections
Acute pelvic infections
Postoperative infections

INVANZ works by interfering with the formation of bacterial cell walls, ultimately leading to the death of the bacteria.
The ?VIAL 1g? designation refers to the specific formulation and dosage of the medication. ?VIAL? indicates that the medication is supplied in a vial for intravenous (IV) administration. The ?1g? indicates that each vial contains 1 gram of ertapenem.
INVANZ is typically administered by a healthcare professional through IV infusion. The dosage and duration of treatment depend on various factors, including the type and severity of the infection, the patient?s age and weight, and their renal function.
As with any antibiotic, INVANZ can cause side effects, though they are generally uncommon. Common side effects may include diarrhea, nausea, vomiting, headache, or injection site reactions. Serious side effects such as allergic reactions or severe diarrhea are rare but possible.
It?s important for healthcare providers to consider the patient?s medical history, current medications, and overall condition before prescribing INVANZ. Patients receiving INVANZ should be monitored closely for any adverse reactions, and appropriate supportive care should be provided as needed.